Back to top

Image: Bigstock

The Zacks Analyst Blog Highlights Pfizer, Booking Holdings, Dominion Energy, Marriott and Nutrien

Read MoreHide Full Article

For Immediate Release

Chicago, IL – June 20, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Pfizer Inc. (PFE - Free Report) , Booking Holdings Inc. (BKNG - Free Report) , Dominion Energy, Inc. (D - Free Report) , Marriott International, Inc. (MAR - Free Report) and Nutrien Ltd. (NTR - Free Report) .

Here are highlights from Friday’s Analyst Blog:

Top Research Reports for Pfizer, Booking.com and Dominion Energy

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc., Booking Holdings Inc. and Dominion Energy, Inc. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
 
You can see all of today's research reports here >>>

Pfizer shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+27.6% vs. +14.0%), reflecting the company's diversified portfolio of innovative drugs and vaccines including Ibrance and Prevnar. The Zacks analyst believes that no company is as strongly placed in the COVID vaccines/treatment market as Pfizer right now. Its COVID-19 vaccine has become a key contributor to the top line.

The vaccine together with Pfizer's promising oral antiviral pill for COVID-19, Paxlovid is expected to generate a combined $54 billion in sales in 2022. Pfizer boasts a sustainable pipeline with multiple late-stage programs that can drive growth.
However, currency headwinds and pricing pressure are key top-line headwinds. Concerns remain about long-term growth drivers beyond its COVID-related products due to competitive pressure.

(You can read the full research report on Pfizer here >>>)

Booking shares have declined -15.6% over the past year against the Zacks Internet - Commerce industry's decline of -48.7% on the back of steady improvement in booking trends. That said, the Zacks analyst sees uncertainties related to the economic outlook and ongoing coronavirus pandemic as still a headwind. 

Additionally, the company is experiencing solid momentum in international regions, which is a positive. Also, strong growth in rental car, airline ticket units and booked room nights is another positive. This apart, solid momentum across the agency, merchant, and advertising and other businesses is contributing well. The ongoing vaccination drive and lifting up of travel restrictions in many parts of the world remain major tailwinds. Further, strengthening alternative accommodation business and flight capabilities are major positives.

(You can read the full research report on Booking here >>>)

Dominion Energy shares have modestly outperformed the Zacks Utility - Electric Power industry over the past year (+1.9% vs. +1.6%). The company's planned investment will strengthen the electric and natural gas infrastructure, and ensure consistent high-quality services for customers. Contribution from organic as well as inorganic assets will boost its earnings.

The divestiture of Gas Transmission & Storage operations will increase Dominion Energy's focus on regulated operations. New clean energy projects will help it achieve carbon neutrality by 2050. The company has enough liquidity to meet obligations. In the past six months, Dominion's shares have outperformed the industry.

However, Dominion Energy's decision to discontinue the Atlantic Coast Pipeline after investing billions of dollars will impact long-term prospects. Risks of operating nuclear power plants and any failure by third-party producers to supply gas could impact profitability.

(You can read the full research report on Dominion Energy here >>>)

Other noteworthy reports we are featuring today include Marriott International, Inc. and Nutrien Ltd.

Why Haven't You Looked at Zacks' Top Stocks?

Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.